Nicolau, J. C., Bhatt, D. L., Hohnloser, S. H., Kimura, T., Lip, G. Y. H., Miede, C., . . . Cannon, C. P. (2020). Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial. Drugs.
Stile di citazione ChicagoNicolau, José C., et al. "Dabigatran Dual Therapy Vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients With Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial." Drugs 2020.
Citazione MLANicolau, José C., et al. "Dabigatran Dual Therapy Vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients With Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial." Drugs 2020.